|
Glycogen Storage Disease Type IV
|
C16.320.565.202.449.540 |
|
|
Retinoblastoma-Binding Protein 4
|
D12.776.930.780.890.200.500 |
|
|
Competitive Medical Plans
|
N03.219.521.576.343.800.175 |
|
|
Bisphenol A-Glycidyl Methacrylate
|
D02.241.081.069.600.150 |
|
|
Graphite
|
D01.578.300 |
|
|
Cardiac Complexes, Premature
|
C14.280.067.325 |
|
|
Erythema Chronicum Migrans
|
C17.800.838.765.310 |
|
|
Sex Reassignment Surgery
|
E04.680.750 |
|
|
Transactinide Series Elements
|
D01.496.749.305.935 |
|
|
Brugada Syndrome
|
C14.280.067.322 |
|
|
HLA-DRB3 Chains
|
D059826 |
[A subtype of HLA-DRB beta chains that includes over 50 allelic variants. The HLA-DRB3 beta-chain subtype is associated with HLA-DR52 serological subtype.
] |
|
Synteny
|
G02.111.810.550.830 |
|
|
Sequence Homology, Nucleic Acid
|
G02.111.810.550 |
|
|
Agricultural Inoculants
|
D059827 |
[Beneficial microorganisms (bacteria or fungi) encapsulated in carrier material and applied to the environment for remediation and enhancement of agricultural productivity.
] |
|
Ancylostoma
|
B01.050.500.500.294.400.968.100.100 |
|
|
Plant Cells
|
D059828 |
[Basic functional unit of plants.
] |
|
Artemether
|
D02.389.338.055.250 |
|
|
Artemisinins
|
D02.389.338.055 |
|
|
Insulin
|
D12.644.548.586.200.500.625 |
|
|
Physical Therapists
|
D059825 |
[Persons trained in PHYSICAL THERAPY SPECIALTY to make use of PHYSICAL THERAPY MODALITIES to prevent, correct, and alleviate movement dysfunction.
] |
